On Tuesday, Nuvation Bio Inc (NYSE: NUVB) opened lower -2.10% from the last session, before settling in for the closing price of $9.54. Price fluctuations for NUVB have ranged from $1.54 to $9.75 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -49.14% annually for the last half of the decade. Company’s average yearly earnings per share was noted 71.52% at the time writing. With a float of $239.39 million, this company’s outstanding shares have now reached $341.76 million.
In an organization with 220 employees, it is important to assess its efficiency.
Nuvation Bio Inc (NUVB) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Nuvation Bio Inc is 30.38%, while institutional ownership is 53.82%. The most recent insider transaction that took place on Dec 01 ’25, was worth 1,173,255. In this transaction CHIEF MEDICAL OFFICER of this company sold 150,000 shares at a rate of $7.82, taking the stock ownership to the 18,000 shares. Before that another transaction happened on Dec 01 ’25, when Company’s Officer proposed sale 150,000 for $7.82, making the entire transaction worth $1,173,255.
Nuvation Bio Inc (NUVB) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.12 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.12) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 71.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 55.84% during the next five years compared to -49.14% drop over the previous five years of trading.
Nuvation Bio Inc (NYSE: NUVB) Trading Performance Indicators
Check out the current performance indicators for Nuvation Bio Inc (NUVB). In the past quarter, the stock posted a quick ratio of 8.39. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 120.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.64, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.50 in one year’s time.
Technical Analysis of Nuvation Bio Inc (NUVB)
Let’s dig in a bit further. During the last 5-days, its volume was 7.11 million. That was better than the volume of 5.64 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 86.95%.
During the past 100 days, Nuvation Bio Inc’s (NUVB) raw stochastic average was set at 94.58%, which indicates a significant increase from 78.97% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.50 in the past 14 days, which was higher than the 0.36 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.34, while its 200-day Moving Average is $3.42. However, in the short run, Nuvation Bio Inc’s stock first resistance to watch stands at $9.57. Second resistance stands at $9.79. The third major resistance level sits at $10.05. If the price goes on to break the first support level at $9.09, it is likely to go to the next support level at $8.83. Assuming the price breaks the second support level, the third support level stands at $8.61.
Nuvation Bio Inc (NYSE: NUVB) Key Stats
There are currently 342,833K shares outstanding in the company with a market cap of 3.21 billion. Presently, the company’s annual sales total 7,870 K according to its annual income of -567,940 K. Last quarter, the company’s sales amounted to 13,120 K and its income totaled -55,790 K.
